Using Numerical Statutory Interpretation to Improve Conflict of Interest Waiver Procedures at the FDA – Note by Saurabh Anand

From Volume 83, Number 4 (May 2010)

Conflicts of interest frequently arise when industry experts advise federal agencies. Critics claim agencies’ decisions to waive conflicts of interest often lack consistency and clarity, but they have yet to propose a comprehensive system to improve the conflict of interest waiver process.



Like this article?

Share on Facebook
Share on Twitter
Share on Linkdin
Share on Pinterest
%d bloggers like this: